Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05615870 · ClinicalTrials.gov registry record · NA
Bronchiolitis Recovery and the Use of High Efficiency Particulate Air (HEPA) Filters
A NA study, sponsored by IDeA States Pediatric Clinical Trials Network.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT05615870: Completed NA study, sponsored by IDeA States Pediatric Clinical Trials Network.
NCT05615870 is a NA study that has completed, run by IDeA States Pediatric Clinical Trials Network. The registered enrollment target is 230 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05615870, a NA study, has completed, sponsored by IDeA States Pediatric Clinical Trials Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
This is a multi-center, parallel, double-blind, randomized controlled clinical trial. Children \<12 months of age hospitalized with bronchiolitis are randomized 1:1 to receive a 24-week home intervention with filtration units containing HEPA and carbon filters (in the child's sleep space and a common room) to improve indoor air quality (IAQ) or to a control group with filtration units without HEPA and carbon filters. The HEPA intervention units and control units will be used for 24 weeks after pre-intervention IAQ measurements. Children are followed for respiratory outcomes over the pre-intervention and intervention periods.
Primary Outcome
An SFD is defined as a 24-hour period without coughing, wheezing, or trouble breathing
Interventions
- OTHER Winix 5500-2 HEPA filtration units
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2024-07-19 |
| Phase | NA |
What the finished NCT05615870 record still lists
NCT05615870 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Winix 5500-2 HEPA filtration units is the first listed.
NCT05615870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05615870 about?
NCT05615870 is a clinical study titled "Bronchiolitis Recovery and the Use of High Efficiency Particulate Air (HEPA) Filters". This is a multi-center, parallel, double-blind, randomized controlled clinical trial. Children \<12 months of age hospitalized with bronchiolitis are randomized 1:1 to receive a 24-week home intervention with filtration units containing HEPA and carbon filters (in the child's sleep space and a commo...
What is the current status of trial NCT05615870?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2022-11-07. Estimated completion is 2024-07-19.
What interventions are being tested in trial NCT05615870?
The interventions under investigation include: Winix 5500-2 HEPA filtration units (OTHER).
Who is sponsoring clinical trial NCT05615870?
This trial is sponsored by IDeA States Pediatric Clinical Trials Network, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05615870's enrollment target sits among peer trials
230 465th of 2000 higher than 1,533 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI